InvestorsHub Logo

pharma_trader

05/29/15 1:22 PM

#88194 RE: pharma_trader #87698

HTBX $7 Heat Biologics, Inc. to Present Interim Immune Response Data From Ongoing Phase II Trial With HS-110 in Advanced NSCLC at ASCO

http://finance.yahoo.com/news/heat-biologics-inc-present-interim-120000991.html